SGRY - サ―ジェリ―・パ―トナ―ズ (Surgery Partners Inc.) サ―ジェリ―・パ―トナ―ズ

 SGRYのチャート


 SGRYの企業情報

symbol SGRY
会社名 Surgery Partners Inc (サ―ジェリ―・パ―トナ―ズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Hospital/Nursing Management  
業種 ヘルスケア施設_サ―ビス   医療関連(Health Care)
概要 事業概要 サージャリ・パートナー(Surgery Partners Inc.)は医療サービス会社である。同社は米国内で3つの事業ラインを運営する。外科施設サービス事業は、麻酔サービスを含む外来手術センター(ASC)と外科病院の運営で構成される。同社の外科施設は、主に胃腸(GI)、一般手術、眼科、整形外科および疼痛管理を含む複数の専門分野にわたる非緊急手術手技を提供する。補助サービス事業は、診断検査室、専門薬局および複数の専門医師の実務で構成される。医師の実務には、長期的な管理サービス契約に基づいて所有・運営されている医師の慣行が含まれる。光学サービス事業は、光学検査室、光学製品グループ購買組織で構成される。   サ―ジェリ―・パ―トナ―ズは米国のヘルスケア・サ―ビス会社。外来患者に対し、質の高いケアをコストを抑えたモデルで医療サ―ビスを提供する。各種疾病診断、診療、外科手術、麻酔、救急処置、眼科治療、薬の処方などを行う。米国28州で99カ所の外科手術センタ―を所有・運営またはパ―トナ―提携をする。本社はテネシ―州ナッシュビル。   Surgery Partners is headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities.
本社所在地 310 Seven Springs Way Suite 500 Brentwood TN 37027 USA
代表者氏名 T. Devin O'Reilly T.デヴィン・オライリー
代表者役職名 Independent Chairman of the board
電話番号 +1 615-234-5900
設立年月日 42095
市場名 NASDAQ National Market System
ipoyear 2015年
従業員数 10600人
url www.surgerypartners.com
nasdaq_url https://www.nasdaq.com/symbol/sgry
adr_tso
EBITDA EBITDA(百万ドル) 252.49800
終値(lastsale) 15.07
時価総額(marketcap) 736954918.26
時価総額 時価総額(百万ドル) 707.12460
売上高 売上高(百万ドル) 1628.827
企業価値(EV) 企業価値(EV)(百万ドル) 3260.5666
当期純利益 当期純利益(百万ドル) -60.51800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Surgery Partners Inc revenues increased 50% to $862.1M. Net loss applicable to common stockholders increased from $7.2M to $52.7M. Revenues reflect Surgical Facility Services segment increase of 56% to $814.5M Optical Services segment remaining flat at $5.7M. Higher net loss reflects Interest Expense - Net increase of 38% to $70.2M (expense).

 SGRYのテクニカル分析


 SGRYのニュース

   Surgery Partners (NASDAQ:SGRY) Announces Earnings Results  2021/11/04 16:08:41 Transcript Daily
Surgery Partners (NASDAQ:SGRY) released its earnings results on Tuesday. The company reported ($0.05) EPS for the quarter, beating analysts consensus estimates of ($0.09) by $0.04, MarketWatch Earnings reports. Surgery Partners had a negative return on equity of 1.93% and a negative net margin of 4.95%. During the same period in the prior year, the company []
   Occudo Quantitative Strategies LP Takes $260,000 Position in Surgery Partners, Inc. (NASDAQ:SGRY)  2021/11/04 12:36:41 Dakota Financial News
Occudo Quantitative Strategies LP purchased a new stake in Surgery Partners, Inc. (NASDAQ:SGRY) during the second quarter, according to its most recent filing with the SEC. The fund purchased 3,902 shares of the companys stock, valued at approximately $260,000. A number of other hedge funds and other institutional investors also recently made changes to their []
   Surgery Partners (NASDAQ:SGRY) Coverage Initiated at JPMorgan Chase & Co.  2021/11/03 06:00:49 Transcript Daily
Equities research analysts at JPMorgan Chase & Co. initiated coverage on shares of Surgery Partners (NASDAQ:SGRY) in a research note issued on Monday, Analyst Price Targets reports. The brokerage set a neutral rating and a $50.00 price target on the stock. JPMorgan Chase & Co.s price objective would indicate a potential upside of 21.80% from []
   Surgery Partners EPS beats by $0.05, beats on revenue  2021/11/02 20:31:47 Seeking Alpha
   Surgery Partners, Inc. (NASDAQ:SGRY) Holdings Increased by Bain Capital Investors LLC  2021/11/01 14:32:48 Transcript Daily
Bain Capital Investors LLC lifted its stake in Surgery Partners, Inc. (NASDAQ:SGRY) by 85.5% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 49,064,576 shares of the company’s stock after buying an additional 22,608,925 shares during the quarter. Surgery Partners makes up 31.9% of Bain […]
   RBC Capital Stick to Their Buy Rating for Surgery Partners Inc By Investing.com  2021/06/14 01:46:57 Investing.com
RBC Capital Stick to Their Buy Rating for Surgery Partners Inc
   Surgery Partners & UCI Health Collaborate to Enhance Surgical Facilities  2021/06/01 08:57:08 Smarter Analyst
Surgery Partners Inc (SGRY) inked a new partnership with UCI Health in a bid to expand their emergency medical service facilities and thereby The post Surgery Partners & UCI Health Collaborate to Enhance Surgical Facilities appeared first on Smarter Analyst .
   Surgery Partners and UCI Health ink strategic partnership  2021/05/28 19:18:26 Seeking Alpha
   Surgery Partners, Inc. and UCI Health Announce New Strategic Partnership  2021/05/28 00:00:00 BioSpace
Surgery Partners, Inc. (NASDAQ:SGRY) and UCI Health have announced a new strategic partnership that marks an expansion of community access to outpatient surgical facilities for nearly 4 million residents throughout Orange County, western Riverside County and southern California.
   Surgery Partners, Inc. to Present at Upcoming Investor Conference - May 26, 2021  2021/05/26 00:00:00 BioSpace
Surgery Partners, Inc., a leading provider of surgical services, announced that Wayne DeVeydt, Executive Chairman of the Board and Tom Cowhey, Chief Financial Officer will meet with investors at the Jefferies Virtual Healthcare Conference, including a presentation on Wednesday, June 2, 2021 at 3:30p.m.
   Surgery Partners and UCI Health ink strategic partnership  2021/05/28 19:18:26 Seeking Alpha
   Surgery Partners Inc Shares Approach 52-Week High - Market Mover  2021/05/12 22:30:00 Kwhen Finance
Surgery Partners Inc (SGRY) shares closed today at 1.4% below its 52 week high of $52.88, giving the company a market cap of $3B. The stock is currently up 79.7% year-to-date, up 445.6% over the past 12 months, and up 267.6% over the past five years. This week, the Dow Jones Industrial Average fell 1.0%, and the S&P 500 fell 1.3%. Trading Activity Trading volume this week was 7.1% higher than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 1.8. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.The stock closed at 2.5% higher than its 5-day moving average, 6.2% higher than its 20-day moving average, and 27.5% higher than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 966.8% The company's stock price performance over the past 12 months beats the peer average by 4519.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 サ―ジェリ―・パ―トナ―ズ SGRY Surgery Partners Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)